Prevention of West Syndrome With Low-dose Adrenocorticotropin Hormone (ACTH)
Condition(s):West SyndromeLast Updated:November 16, 2018Unknown status
Hide Studies Not Open or Pending
Condition(s):West SyndromeLast Updated:November 16, 2018Unknown status
Condition(s):Multiple SclerosisLast Updated:March 22, 2016Terminated
Condition(s):Postural Tachycardia SyndromeLast Updated:March 31, 2022Completed
Condition(s):Adult Growth Hormone Deficiency; Hypothalamic-pituitary DisordersLast Updated:May 17, 2017Completed
Condition(s):DevelopmentLast Updated:August 26, 2019Completed
Condition(s):Hyperandrogenemia; Obesity; Polycystic Ovary SyndromeLast Updated:July 19, 2018Withdrawn
Condition(s):Metabolic Syndrome; Hypersecretion; CortisolLast Updated:August 23, 2016Completed
Condition(s):ACTH; Cushing’s SyndromeLast Updated:February 23, 2024Recruiting
Condition(s):Multiple SclerosisLast Updated:January 5, 2021Withdrawn
Condition(s):Cocaine DependenceLast Updated:June 5, 2023Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.